MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Zimmer Biomet Holdings Retained Earnings 2011-2026 | ZBH
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Zimmer Biomet Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.1 B | 10.4 B | 9.56 B | 10.3 B | 10.1 M | 10.4 B | 9.49 B | 10 B | 8.47 B | 8.35 B | 8.29 B | 7.71 B | 7.09 B | 6.43 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.1 B | 10.1 M | 8.4 B |
Quarterly Retained Earnings Zimmer Biomet Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.5 B | 11.3 B | 11.2 B | 10.9 B | 10.7 B | 10.5 B | 10 B | 9.9 B | 9.74 B | 9.56 B | 9.74 B | - | 9.5 B | 10.3 B | 10.4 B | 10.3 B | 10.3 B | 10.1 B | 10.1 B | 10.1 B | 10.1 B | 10.4 B | 10.4 B | 10.4 B | 10.4 B | 9.49 B | 9.49 B | 9.49 B | 9.49 B | 10 B | 10 B | 10 B | 10 B | 8.47 B | 8.47 B | 8.47 B | 8.47 B | 8.35 B | 8.35 B | 8.35 B | 8.35 B | 8.36 B | 8.36 B | 8.29 B | 8.29 B | 7.71 B | 7.71 B | 7.71 B | 7.71 B | 7.09 B | 7.09 B | 7.09 B | 7.09 B | 6.43 B | 6.43 B | 6.43 B | 6.43 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 11.5 B | 6.43 B | 9.14 B |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.24 | 3.7 % | $ 1.36 M |  USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 17.22 | 1.06 % | $ 404 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 65.3 | 13.39 % | $ 3.56 B |  Britain |
 |
Myomo
MYO
|
-119 M | $ 0.85 | -3.31 % | $ 35.6 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Orthofix Medical
OFIX
|
-368 M | $ 12.31 | -1.05 % | $ 488 M |  Curacao |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 7.03 | -31.33 % | $ 1.05 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.6 | 4.35 % | $ 135 M |  France |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Insulet Corporation
PODD
|
287 M | $ 153.66 | -8.28 % | $ 10.8 B | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Sintx Technologies
SINT
|
-292 M | $ 2.55 | 5.17 % | $ 7.07 M | USA |
 |
Stryker Corporation
SYK
|
20.5 B | $ 290.82 | -1.51 % | $ 111 B | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 11.14 | 0.36 % | $ 315 M | USA |
 |
TransMedics Group
TMDX
|
-278 M | $ 73.07 | -23.03 % | $ 2.48 B | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Tandem Diabetes Care
TNDM
|
-1.25 B | $ 18.16 | -6.49 % | $ 1.24 B | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.61 | 0.38 % | $ 38 M | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 11.45 | -0.69 % | $ 410 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Varex Imaging Corporation
VREX
|
-5.9 M | $ 11.81 | 2.43 % | $ 489 M | USA |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.05 | -0.48 % | $ 17.8 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
21.2 M | $ 26.15 | 1.32 % | $ 221 M | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 4.68 | -2.8 % | $ 991 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 89.54 | -0.54 % | $ 12.1 B | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 36.55 | -0.25 % | $ 1.13 B | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 46.39 | -3.85 % | $ 1.36 B | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 87.11 | 1.47 % | $ 3.03 B | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 82.49 | -0.51 % | $ 48.2 B | USA |
 |
Tactile Systems Technology
TCMD
|
54.9 M | $ 24.4 | 1.46 % | $ 558 M | USA |